Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antidepressant |
| gptkbp:ATCCode |
N06AX03
|
| gptkbp:CASNumber |
41177-08-4
|
| gptkbp:developedBy |
gptkb:Hoechst_AG
|
| gptkbp:hasMolecularFormula |
C16H18N2O
|
| gptkbp:hasSMILES |
CC1=CC2=C(C=C1)N(C3=CC=CC=C3)CCCN2
|
| https://www.w3.org/2000/01/rdf-schema#label |
nomifensine
|
| gptkbp:IUPACName |
1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine
|
| gptkbp:legalStatus |
withdrawn
|
| gptkbp:mechanismOfAction |
norepinephrine reuptake inhibitor
|
| gptkbp:meltingPoint |
120–121 °C
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1427
4537 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
jaundice allergic reactions liver dysfunction |
| gptkbp:synonym |
gptkb:Hoe_984
gptkb:Merital |
| gptkbp:UNII |
8KQ660G10X
|
| gptkbp:usedFor |
treatment of depression
|
| gptkbp:withdrawn |
1986
risk of hemolytic anemia |
| gptkbp:bfsParent |
gptkb:dopamine_transporter
|
| gptkbp:bfsLayer |
7
|